Needham analyst David Saxon initiated coverage with a Buy rating on Alcon (ALC – Research Report) today and set a price target of $95.00. The company's shares closed last Tuesday at $65.29, close to its 52-week low of $63.92. According to TipRanks.com, Saxon is currently ranked with 0 stars on a 0-5 stars ranking scale, with an average return of -15.8% and a 13.1% success rate. Saxon covers the Healthcare sector, focusing on stocks such as Irhythm Technologies, Alphatec Holdings, and Globus Medical. Alcon has an analyst consensus of Moderate Buy, with a price target consensus of $85.96.
https://www.tipranks.com/news/blurbs/needham-thinks-alcons-stock-is-going-to-recover?utm_source=advfn.com&utm_medium=referral